| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,767 |
7,285 |
$477K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,319 |
2,756 |
$159K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,311 |
3,347 |
$118K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
583 |
468 |
$37K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
896 |
414 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
155 |
142 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
628 |
525 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
301 |
212 |
$973.04 |
| 81003 |
|
472 |
367 |
$848.34 |
| 86710 |
|
60 |
48 |
$677.60 |
| 81001 |
|
70 |
62 |
$253.42 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
166 |
136 |
$228.80 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
368 |
263 |
$118.57 |
| 81002 |
|
18 |
18 |
$64.29 |
| 3079F |
|
273 |
241 |
$0.00 |
| 3080F |
|
211 |
181 |
$0.00 |
| 3074F |
|
265 |
230 |
$0.00 |
| 3075F |
|
13 |
13 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
26 |
25 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
12 |
$0.00 |
| 3077F |
|
288 |
237 |
$0.00 |
| 3078F |
|
150 |
130 |
$0.00 |